Diamedica Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Diamedica Therapeutics (DMAC) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Diamedica Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Diamedica Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Diamedica Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $88k | 13k | 6.87 |
| 2024-09-30 | $113 | 27 | 4.19 |
| 2023-12-31 | $1.6k | 564 | 2.84 |
| 2023-09-30 | $65 | 25 | 2.60 |
| 2023-06-30 | $90 | 21 | 4.33 |
| 2020-09-30 | $0 | 8 | 0.00 |
| 2020-06-30 | $0 | 8 | 0.00 |